Deni Aldo Procaccini

Enzyme replacement therapy with agalsidase β improves cardiac involvement in Fabry's disease

Letìzia Spinelli, Antonio Pisani, Massimo Sabbatini et al. · Clinical Genetics · 2004 · 117 citations

Medicine, Cardiology, Clinical Sciences +14

Enzyme Replacement Therapy in Fabry Disease Patients Undergoing Dialysis: Effects on Quality of Life and Organ Involvement

Antonio Pisani, Letìzia Spinelli, Massimo Sabbatini et al. · American Journal of Kidney Diseases · 2005 · 72 citations

Medicine, Internal Medicine, Nephrology +14

Effect of Coexistent Diseases on Survival of Patients Undergoing Dialysis

Antonio Nicolucci, DOLLY CUBASSO, D. Labbrozzi et al. · ASAIO Journal · 1992 · 60 citations

Medicine, Internal Medicine, Nephrology +14

Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy

Renzo Mignani, Sandro Feriozzi, Antonio Pisani et al. · Nephrology Dialysis Transplantation · 2007 · 54 citations · Full text

Medicine, Cardiology, Nephrology +14

The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial

Valeria Saglimbene, Suetonia C. Palmer, Marinella Ruospo et al. · Journal of the American Society of Nephrology · 2018 · 38 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17